Sweden Pharmacogenomics Technology Market Size & Outlook
Related Markets
Sweden pharmacogenomics technology market highlights
- The Sweden pharmacogenomics technology market generated a revenue of USD 30.2 million in 2024 and is expected to reach USD 58.3 million by 2030.
- The Sweden market is expected to grow at a CAGR of 11.5% from 2025 to 2030.
- In terms of segment, oncology was the largest revenue generating therapeutics area in 2024.
- Cardiovascular Disease is the most lucrative therapeutics area segment registering the fastest growth during the forecast period.
Pharmacogenomics technology market data book summary
| Market revenue in 2024 | USD 30.2 million |
| Market revenue in 2030 | USD 58.3 million |
| Growth rate | 11.5% (CAGR from 2025 to 2030) |
| Largest segment | Oncology |
| Fastest growing segment | Cardiovascular Disease |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Neurological Disorders, Cardiovascular Disease, Immunological Disorders, Infectious Diseases, Oncology |
| Key market players worldwide | Qiagen NV, GE HealthCare Technologies Inc Common Stock, Agilent Technologies Inc, Roche Holding AG ADR, Thermo Fisher Scientific Inc, Pfizer Inc, Leica Biosystems, Foundation Medicine |
Other key industry trends
- In terms of revenue, Sweden accounted for 0.4% of the global pharmacogenomics technology market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, Germany pharmacogenomics technology market is projected to lead the regional market in terms of revenue in 2030.
- Norway is the fastest growing regional market in Europe and is projected to reach USD 47.5 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Pharmacogenomics Technology Market Scope
Pharmacogenomics Technology Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Leica Biosystems | View profile | 1001-5000 | Nußloch, Baden-Wurttemberg, Germany, Europe | http://www.leicabiosystems.com/ |
| Foundation Medicine | View profile | 251-500 | Cambridge, Massachusetts, United States, North America | http://www.foundationmedicine.com |
| Qiagen NV | View profile | 5900 | Hulsterweg 82, Venlo, LI, Netherlands, 5912 PL | https://www.qiagen.com |
| Agilent Technologies Inc | View profile | 17700 | 5301 Stevens Creek Boulevard, Santa Clara, CA, United States, 95051 | https://www.agilent.com |
| Thermo Fisher Scientific Inc | View profile | 122000 | 168 Third Avenue, Waltham, MA, United States, 02451 | https://www.thermofisher.com |
| Pfizer Inc | View profile | 88000 | 66 Hudson Boulevard East, New York, NY, United States, 10001-2192 | https://www.pfizer.com |
| GE HealthCare Technologies Inc Common Stock | View profile | 51000 | 500 West Monroe Street, Chicago, IL, United States, 60661 | https://www.gehealthcare.com |
| Roche Holding AG ADR | View profile | 103605 | Grenzacherstrasse 124, Basel, Switzerland, 4070 | https://www.roche.com |
Sweden pharmacogenomics technology market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to pharmacogenomics technology market will help companies and investors design strategic landscapes.
Oncology was the largest segment with a revenue share of 44.7% in 2024. Horizon Databook has segmented the Sweden pharmacogenomics technology market based on neurological disorders, cardiovascular disease, immunological disorders, infectious diseases, oncology covering the revenue growth of each sub-segment from 2018 to 2030.
Reasons to subscribe to Sweden pharmacogenomics technology market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Sweden pharmacogenomics technology market databook
-
Our clientele includes a mix of pharmacogenomics technology market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Sweden pharmacogenomics technology market , including forecasts for subscribers. This country databook contains high-level insights into Sweden pharmacogenomics technology market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Sweden pharmacogenomics technology market size, by therapeutics area, 2018-2030 (US$M)
Sweden Pharmacogenomics Technology Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
